drugset / Trial / NCT00389753
Aruba Aloë Formula F-BC-096 in the Treatment of Split Thickness Donor Sites After Wound Closure
Withdrawn
University Hospital, Ghent
RandomizedSingle-groupDouble-blindTreatment
Summary
Comparison between use of Aruba Aloë formula F-BC-096 and control.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Outcome
Outcome not reported
Stopped: “study never started”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aruba Aloë formula F-BC-096 | Unknown | — | — |
Indications
No indication recorded.